ArticleJournal of medical case reports2021

Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report.

Rosa Montero-Macias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.